BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8844806)

  • 1. Activation and detoxication of carcinogenic arylamines by sulfation.
    Yamazoe Y; Nagata K; Ozawa S; Gong DW; Kato R
    Princess Takamatsu Symp; 1995; 23():154-62. PubMed ID: 8844806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
    Chou HC; Lang NP; Kadlubar FF
    Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
    Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
    Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene.
    Nagata K; Ozawa S; Miyata M; Shimada M; Gong DW; Yamazoe Y; Kato R
    J Biol Chem; 1993 Nov; 268(33):24720-5. PubMed ID: 8227031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
    Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF
    Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases.
    Ozawa S; Chou HC; Kadlubar FF; Nagata K; Yamazoe Y; Kato R
    Jpn J Cancer Res; 1994 Dec; 85(12):1220-8. PubMed ID: 7852185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals.
    Abu-Zeid M; Yamazoe Y; Kato R
    Carcinogenesis; 1992 Aug; 13(8):1307-14. PubMed ID: 1499081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of ST1C1-related human sulfotransferase.
    Yoshinari K; Nagata K; Shimada M; Yamazoe Y
    Carcinogenesis; 1998 May; 19(5):951-3. PubMed ID: 9635888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases.
    Ozawa S; Nagata K; Yamazoe Y; Kato R
    Jpn J Cancer Res; 1995 Mar; 86(3):264-9. PubMed ID: 7744696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfotransferase catalyzing sulfation of heterocyclic amines.
    Yamazoe Y; Nagata K; Yoshinari K; Fujita K; Shiraga T; Iwasaki K
    Cancer Lett; 1999 Sep; 143(2):103-7. PubMed ID: 10503886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and expression of hepatic sulfotransferase involved in the metabolism of N-substituted aryl compounds.
    Yamazoe Y; Ozawa S; Nagata K; Gong DW; Kato R
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):99-103. PubMed ID: 7889867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine activating sulfotransferase in liver.
    Nagata K; Yoshinari K; Ozawa S; Yamazoe Y
    Mutat Res; 1997 May; 376(1-2):267-72. PubMed ID: 9202764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.
    King RS; Teitel CH; Kadlubar FF
    Carcinogenesis; 2000 Jul; 21(7):1347-54. PubMed ID: 10874013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens.
    Banoglu E
    Curr Drug Metab; 2000 Jul; 1(1):1-30. PubMed ID: 11467078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding activity of natto (a fermented food) and Bacillus natto isolates to mutagenic-carcinogenic heterocyclic amines.
    Rajendran R; Ohta Y
    Can J Microbiol; 2001 Oct; 47(10):935-42. PubMed ID: 11718547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.
    Davis CD; Schut HA; Snyderwine EG
    Carcinogenesis; 1993 Oct; 14(10):2091-6. PubMed ID: 8222059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses.
    Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N
    Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines.
    Muckel E; Frandsen H; Glatt HR
    Food Chem Toxicol; 2002 Aug; 40(8):1063-8. PubMed ID: 12067565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfotransferase- and acetyltransferase-mediated activation of carcinogenic N-hydroxyarylamines in mammals and bacteria, and their modulation by thiols.
    Yamazoe Y; Abu-Zeid M; Staiano N; Kato R
    Basic Life Sci; 1993; 61():161-9. PubMed ID: 8304927
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity.
    Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
    Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.